{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T02:46:46Z","timestamp":1789181206027,"version":"build-2803163510"},"reference-count":70,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","theclinics.com","gastro.theclinics.com","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gastroenterology Clinics of North America"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1016\/j.gtc.2017.01.004","type":"journal-article","created":{"date-parts":[[2017,5,13]],"date-time":"2017-05-13T00:30:58Z","timestamp":1494635458000},"page":"273-296","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":67,"title":["Drug-induced Liver Injury"],"prefix":"10.1016","volume":"46","author":[{"given":"David E.","family":"Kleiner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.gtc.2017.01.004_bib1","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1053\/j.gastro.2008.09.011","article-title":"Causes, clinical features, and outcomes from a prospective study of drug-induced liver injury in the United States","volume":"135","author":"Chalasani","year":"2008","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.gtc.2017.01.004_bib2","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0168-8278(99)80297-9","article-title":"International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis","volume":"31","author":"Alvarez","year":"1999","journal-title":"J\u00a0Hepatol"},{"issue":"1","key":"10.1016\/j.gtc.2017.01.004_bib3","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/hep.22322","article-title":"Simplified criteria for the diagnosis of autoimmune hepatitis","volume":"48","author":"Hennes","year":"2008","journal-title":"Hepatology"},{"issue":"11","key":"10.1016\/j.gtc.2017.01.004_bib4","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/0895-4356(93)90101-6","article-title":"Causality assessment of adverse reactions to drugs\u2013I. A novel method based on the conclusions of international consensus meetings: application to drug-induced liver injuries","volume":"46","author":"Danan","year":"1993","journal-title":"J\u00a0Clin Epidemiol"},{"issue":"4","key":"10.1016\/j.gtc.2017.01.004_bib5","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1002\/hep.21335","article-title":"Modeling hepatic fibrosis in African American and Caucasian American patients with chronic hepatitis C virus infection","volume":"44","author":"Fontana","year":"2006","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.gtc.2017.01.004_bib6","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0168-8278(03)00191-0","article-title":"Impact of liver biopsy size on histological evaluation of chronic viral hepatitis: the smaller the sample, the milder the disease","volume":"39","author":"Colloredo","year":"2003","journal-title":"J\u00a0Hepatol"},{"issue":"9","key":"10.1016\/j.gtc.2017.01.004_bib7","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/S1542-3565(05)00541-0","article-title":"Importance of specimen size in accurate needle liver biopsy evaluation of patients with chronic hepatitis C","volume":"3","author":"Schiano","year":"2005","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"7","key":"10.1016\/j.gtc.2017.01.004_bib8","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1053\/j.gastro.2005.03.084","article-title":"Sampling variability of liver biopsy in nonalcoholic fatty liver disease","volume":"128","author":"Ratziu","year":"2005","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.gtc.2017.01.004_bib9","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1097\/PAS.0b013e3182082ef6","article-title":"The concept of hepatic artery-bile duct parallelism in the diagnosis of ductopenia in liver biopsy samples","volume":"35","author":"Moreira","year":"2011","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"10.1016\/j.gtc.2017.01.004_bib10","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1002\/hep.510280206","article-title":"The normal adult human liver biopsy: a quantitative reference standard","volume":"28","author":"Crawford","year":"1998","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.gtc.2017.01.004_bib11","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1034\/j.1600-0676.2001.210605.x","article-title":"Large-needle biopsy versus thin-needle biopsy in diagnostic pathology of liver diseases","volume":"21","author":"Rocken","year":"2001","journal-title":"Liver"},{"issue":"3","key":"10.1016\/j.gtc.2017.01.004_bib12","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1002\/hep.22742","article-title":"Liver biopsy","volume":"49","author":"Rockey","year":"2009","journal-title":"Hepatology"},{"issue":"12","key":"10.1016\/j.gtc.2017.01.004_bib13","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1038\/modpathol.2010.175","article-title":"Aberrant expression of cytokeratin 7 in perivenular hepatocytes correlates with a cholestatic chemistry profile in patients with heart failure","volume":"23","author":"Pai","year":"2010","journal-title":"Mod Pathol"},{"issue":"10","key":"10.1016\/j.gtc.2017.01.004_bib14","first-page":"1089","article-title":"Atrophic hepatocytes express keratin 7 in ischemia-associated liver lesions","volume":"31","author":"Delladetsima","year":"2016","journal-title":"Histol Histopathol"},{"issue":"2","key":"10.1016\/j.gtc.2017.01.004_bib15","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1002\/hep.26709","article-title":"Hepatic histological findings in suspected drug-induced liver injury: systematic evaluation and clinical associations","volume":"59","author":"Kleiner","year":"2014","journal-title":"Hepatology"},{"issue":"8","key":"10.1016\/j.gtc.2017.01.004_bib16","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1007\/s10620-016-4121-6","article-title":"Amoxicillin-clavulanate-induced liver injury","volume":"61","author":"deLemos AS","year":"2016","journal-title":"Dig Dis Sci"},{"issue":"3","key":"10.1016\/j.gtc.2017.01.004_bib17","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1136\/gut.33.3.368","article-title":"Hepatitis associated with amoxycillin-clavulanic acid combination report of 15 cases","volume":"33","author":"Larrey","year":"1992","journal-title":"Gut"},{"issue":"4","key":"10.1016\/j.gtc.2017.01.004_bib18","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1097\/01.mpg.0000178086.44155.73","article-title":"Vanishing bile duct syndrome: amoxicillin-clavulanic acid associated intra-hepatic cholestasis responsive to ursodeoxycholic acid","volume":"41","author":"Smith","year":"2005","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.gtc.2017.01.004_bib19","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1001\/archinte.1965.03860140008003","article-title":"Drug-induced liver disease: a penalty for progress","volume":"115","author":"Popper","year":"1965","journal-title":"Arch Intern Med"},{"issue":"1","key":"10.1016\/j.gtc.2017.01.004_bib20","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.cgh.2016.05.043","article-title":"Features of autoimmune hepatitis in patients with drug-induced liver injury","volume":"15","author":"de Boer","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"7024","key":"10.1016\/j.gtc.2017.01.004_bib21","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1136\/bmj.312.7024.169","article-title":"Minocycline induced autoimmune hepatitis and systemic lupus erythematosus-like syndrome","volume":"312","author":"Gough","year":"1996","journal-title":"BMJ"},{"issue":"2","key":"10.1016\/j.gtc.2017.01.004_bib22","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1002\/hep.27157","article-title":"Spectrum of statin hepatotoxicity: experience of the drug-induced liver injury network","volume":"60","author":"Russo","year":"2014","journal-title":"Hepatology"},{"issue":"8","key":"10.1016\/j.gtc.2017.01.004_bib23","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1097\/00004836-200609000-00018","article-title":"Autoimmune hepatitis triggered by statins","volume":"40","author":"Alla","year":"2006","journal-title":"J\u00a0Clin Gastroenterol"},{"issue":"9","key":"10.1016\/j.gtc.2017.01.004_bib24","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1097\/PAS.0b013e31802ffdd5","article-title":"Epstein-Barr virus hepatitis: diagnostic value of in\u00a0situ hybridization, polymerase chain reaction, and immunohistochemistry on liver biopsy from immunocompetent patients","volume":"31","author":"Suh","year":"2007","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"10.1016\/j.gtc.2017.01.004_bib25","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1136\/ard.2002.001826","article-title":"Hepatic manifestations of autoimmune rheumatic diseases","volume":"63","author":"Abraham","year":"2004","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1016\/j.gtc.2017.01.004_bib26","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1007\/s10875-013-9873-6","article-title":"Nodular regenerative hyperplasia in common variable immunodeficiency","volume":"33","author":"Fuss","year":"2013","journal-title":"J\u00a0Clin Immunol"},{"issue":"5","key":"10.1016\/j.gtc.2017.01.004_bib27","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1111\/bjd.12501","article-title":"Drug reaction with eosinophilia and systemic symptoms (DRESS): an original multisystem adverse drug reaction. Results from the prospective RegiSCAR study","volume":"169","author":"Kardaun","year":"2013","journal-title":"Br J Dermatol"},{"issue":"6","key":"10.1016\/j.gtc.2017.01.004_bib28","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/S0168-8278(98)80357-7","article-title":"Sarcoidosis associated with interferon-alpha therapy for chronic hepatitis C","volume":"28","author":"Hoffmann","year":"1998","journal-title":"J\u00a0Hepatol"},{"issue":"2","key":"10.1016\/j.gtc.2017.01.004_bib29","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1002\/hep.25657","article-title":"Source and characterization of hepatic macrophages in acetaminophen-induced acute liver failure in humans","volume":"56","author":"Antoniades","year":"2012","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.gtc.2017.01.004_bib30","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.taap.2006.04.010","article-title":"Pathophysiological role of the acute inflammatory response during acetaminophen hepatotoxicity","volume":"216","author":"Cover","year":"2006","journal-title":"Toxicol Appl Pharmacol"},{"issue":"5","key":"10.1016\/j.gtc.2017.01.004_bib31","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1002\/hep.1840190515","article-title":"Veno-occlusive disease of the liver after marrow transplantation: histological correlates of clinical signs and symptoms","volume":"19","author":"Shulman","year":"1994","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.gtc.2017.01.004_bib32","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1055\/s-2008-1040724","article-title":"Hepatic lesions caused by anabolic and contraceptive steroids","volume":"1","author":"Ishak","year":"1981","journal-title":"Semin Liver Dis"},{"issue":"2","key":"10.1016\/j.gtc.2017.01.004_bib33","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.gastrohep.2013.09.009","article-title":"Stanozolol-induced bland cholestasis","volume":"37","author":"Ampuero","year":"2014","journal-title":"Gastroenterol Hepatol"},{"issue":"8","key":"10.1016\/j.gtc.2017.01.004_bib34","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1111\/liv.12216","article-title":"Hepatotoxicity from anabolic androgenic steroids marketed as dietary supplements: contribution from ATP8B1\/ABCB11 mutations?","volume":"33","author":"El Sherrif","year":"2013","journal-title":"Liver Int"},{"key":"10.1016\/j.gtc.2017.01.004_bib35","doi-asserted-by":"crossref","first-page":"e468","DOI":"10.1136\/bmj.e468","article-title":"Cholestasis secondary to anabolic steroid use in young men","volume":"344","author":"Elsharkawy","year":"2012","journal-title":"BMJ"},{"issue":"3","key":"10.1016\/j.gtc.2017.01.004_bib36","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s11154-015-9320-5","article-title":"Doping with anabolic androgenic steroids (AAS): adverse effects on non-reproductive organs and functions","volume":"16","author":"Nieschlag","year":"2015","journal-title":"Rev Endocr Metab Disord"},{"issue":"1","key":"10.1016\/j.gtc.2017.01.004_bib37","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0046-8177(82)80134-2","article-title":"Bile ductular cholestasis: an ominous histopathologic sign related to sepsis and \u201ccholangitis lenta.\u201d","volume":"13","author":"Lefkowitch","year":"1982","journal-title":"Hum Pathol"},{"issue":"1","key":"10.1016\/j.gtc.2017.01.004_bib38","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/hep.510280133","article-title":"Clinicopathology conferences: inflammation-induced cholestasis","volume":"28","author":"Crawford","year":"1998","journal-title":"Hepatology"},{"issue":"10","key":"10.1016\/j.gtc.2017.01.004_bib39","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1038\/ajg.2015.283","article-title":"Persistent liver biochemistry abnormalities are more common in older patients and those with cholestatic drug induced liver injury","volume":"110","author":"Fontana","year":"2015","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"10.1016\/j.gtc.2017.01.004_bib40","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1002\/hep.1840090209","article-title":"Floxuridine-induced sclerosing cholangitis: an ischemic cholangiopathy?","volume":"9","author":"Ludwig","year":"1989","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.gtc.2017.01.004_bib41","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1055\/s-0034-1375964","article-title":"Severe ductopenia and cholestasis from levofloxacin drug-induced liver injury: a case report and review","volume":"34","author":"Levine","year":"2014","journal-title":"Semin Liver Dis"},{"issue":"6","key":"10.1016\/j.gtc.2017.01.004_bib42","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.cgh.2011.02.019","article-title":"Clinical and histopathologic features of fluoroquinolone-induced liver injury","volume":"9","author":"Orman","year":"2011","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"5","key":"10.1016\/j.gtc.2017.01.004_bib43","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1007\/s10620-012-2493-9","article-title":"Clinical and histological features of idiosyncratic acute liver injury caused by temozolomide","volume":"58","author":"Grant","year":"2013","journal-title":"Dig Dis Sci"},{"issue":"5750","key":"10.1016\/j.gtc.2017.01.004_bib44","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1136\/bmj.1.5750.625","article-title":"Liver damage due to methotrexate in patients with psoriasis","volume":"1","author":"Dahl","year":"1971","journal-title":"Br Med J"},{"issue":"4","key":"10.1016\/j.gtc.2017.01.004_bib45","first-page":"489","article-title":"Liver biopsy findings in patients with rheumatoid arthritis undergoing longterm treatment with methotrexate","volume":"16","author":"Rau","year":"1989","journal-title":"J\u00a0Rheumatol"},{"issue":"3","key":"10.1016\/j.gtc.2017.01.004_bib46","first-page":"262","article-title":"Liver biopsies from psoriatics related to methotrexate therapy. 2. Findings before and after methotrexate therapy in 88 patients. A blind study","volume":"84","author":"Nyfors","year":"1976","journal-title":"Acta Pathol Microbiol Scand A"},{"issue":"5","key":"10.1016\/j.gtc.2017.01.004_bib47","doi-asserted-by":"crossref","first-page":"275","DOI":"10.4254\/wjh.v5.i5.275","article-title":"Prevalence and risk factors of methotrexate hepatoxicity in Asian patients with psoriasis","volume":"5","author":"Yeo","year":"2013","journal-title":"World J Hepatol"},{"issue":"1","key":"10.1016\/j.gtc.2017.01.004_bib48","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/0046-8177(90)90076-H","article-title":"Histopathologic analysis of suspected amiodarone hepatotoxicity","volume":"21","author":"Lewis","year":"1990","journal-title":"Hum Pathol"},{"issue":"9146","key":"10.1016\/j.gtc.2017.01.004_bib49","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/S0140-6736(05)74872-8","article-title":"Cirrhosis with steatohepatitis after adjuvant tamoxifen","volume":"353","author":"Oien","year":"1999","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.gtc.2017.01.004_bib50","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/0163-7258(95)00012-6","article-title":"Inhibition of mitochondrial beta-oxidation as a mechanism of hepatotoxicity","volume":"67","author":"Fromenty","year":"1995","journal-title":"Pharmacol Ther"},{"issue":"3","key":"10.1016\/j.gtc.2017.01.004_bib51","first-page":"192","article-title":"Histopathologic changes associated with fialuridine hepatotoxicity","volume":"10","author":"Kleiner","year":"1997","journal-title":"Mod Pathol"},{"issue":"8","key":"10.1016\/j.gtc.2017.01.004_bib52","doi-asserted-by":"crossref","first-page":"3592","DOI":"10.1073\/pnas.93.8.3592","article-title":"Fialuridine and its metabolites inhibit DNA polymerase gamma at sites of multiple adjacent analog incorporation, decrease mtDNA abundance, and cause mitochondrial structural defects in cultured hepatoblasts","volume":"93","author":"Lewis","year":"1996","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"issue":"4","key":"10.1016\/j.gtc.2017.01.004_bib53","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1136\/sti.79.4.340","article-title":"Lactic acidosis in HIV infected patients: a systematic review of published cases","volume":"79","author":"Arenas-Pinto","year":"2003","journal-title":"Sex Transm Infect"},{"issue":"1","key":"10.1016\/j.gtc.2017.01.004_bib54","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1086\/313594","article-title":"Lactic acidosis associated with stavudine administration: a report of five cases","volume":"30","author":"Mokrzycki","year":"2000","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.gtc.2017.01.004_bib55","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1055\/s-2003-36654","article-title":"Fatty liver and increased serum lactate in a woman with HIV","volume":"128","author":"Lichterfeld","year":"2003","journal-title":"Dtsch Med Wochenschr"},{"issue":"3","key":"10.1016\/j.gtc.2017.01.004_bib56","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1007\/s13181-010-0047-0","article-title":"Severe drug-induced liver injury associated with prolonged use of linezolid","volume":"6","author":"De Bus","year":"2010","journal-title":"J\u00a0Med Toxicol"},{"issue":"2","key":"10.1016\/j.gtc.2017.01.004_bib57","first-page":"131","article-title":"Phenytoin-induced systemic granulomatous vasculitis","volume":"110","author":"Gaffey","year":"1986","journal-title":"Arch Pathol Lab Med"},{"issue":"4","key":"10.1016\/j.gtc.2017.01.004_bib58","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1093\/ajcp\/74.4.442","article-title":"Hepatic injury associated with diphenylhydantoin therapy. A clinicopathologic study of 20 cases","volume":"74","author":"Mullick","year":"1980","journal-title":"Am J Clin Pathol"},{"issue":"1","key":"10.1016\/j.gtc.2017.01.004_bib59","first-page":"33","article-title":"Definitive diagnosis of hepatic sinusoidal obstruction syndrome induced by pyrrolizidine alkaloids","volume":"13","author":"Gao","year":"2012","journal-title":"J\u00a0Dig Dis"},{"issue":"6","key":"10.1016\/j.gtc.2017.01.004_bib60","first-page":"838","article-title":"Nodular regenerative hyperplasia of the liver in a patient with rheumatoid vasculitis: a morphometric study suggesting a role for hepatic arteritis in the pathogenesis","volume":"11","author":"Reynolds","year":"1984","journal-title":"J\u00a0Rheumatol"},{"issue":"4","key":"10.1016\/j.gtc.2017.01.004_bib61","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1002\/ajh.20024","article-title":"Nodular regenerative hyperplasia of the liver: an under-recognized cause of portal hypertension in hematological disorders","volume":"75","author":"Al-Mukhaizeem","year":"2004","journal-title":"Am J Hematol"},{"issue":"4","key":"10.1016\/j.gtc.2017.01.004_bib62","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1097\/00000478-200604000-00012","article-title":"Glycogenic hepatopathy: an underrecognized hepatic complication of diabetes mellitus","volume":"30","author":"Torbenson","year":"2006","journal-title":"Am J Surg Pathol"},{"issue":"6","key":"10.1016\/j.gtc.2017.01.004_bib63","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1002\/hep.23588","article-title":"Drug-induced autoimmune hepatitis: clinical characteristics and prognosis","volume":"51","author":"Bjornsson","year":"2010","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.gtc.2017.01.004_bib64","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1002\/hep.24481","article-title":"The use of liver biopsy evaluation in discrimination of idiopathic autoimmune hepatitis versus drug-induced liver injury","volume":"54","author":"Suzuki","year":"2011","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.gtc.2017.01.004_bib65","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s00428-013-1528-8","article-title":"Consensus on the histopathological evaluation of liver biopsies from patients following allogeneic hematopoietic cell transplantation","volume":"464","author":"Stift","year":"2014","journal-title":"Virchows Arch"},{"issue":"S2","key":"10.1016\/j.gtc.2017.01.004_bib66","first-page":"426A","article-title":"A\u00a0novel histologic diagnostic algorithm for hepatic graft versus host disease","volume":"29","author":"Stueck","year":"2016","journal-title":"Mod Pathol"},{"issue":"3","key":"10.1016\/j.gtc.2017.01.004_bib67","first-page":"613","article-title":"Teaching monograph. Tissue reactions to drugs","volume":"82","author":"Irey","year":"1976","journal-title":"Am J Pathol"},{"issue":"7","key":"10.1016\/j.gtc.2017.01.004_bib68","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1016\/j.cgh.2014.11.036","article-title":"Identification and characterization of cefazolin-induced liver injury","volume":"13","author":"Alqahtani","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.gtc.2017.01.004_bib69","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1002\/hep.28323","article-title":"Categorization of drugs implicated in causing liver injury: critical assessment based on published case reports","volume":"63","author":"Bjornsson","year":"2016","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.gtc.2017.01.004_bib70","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/cld.371","article-title":"Liver histology in the diagnosis and prognosis of drug-induced liver injury","volume":"4","author":"Kleiner","year":"2014","journal-title":"Clin Liver Dis"}],"container-title":["Gastroenterology Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889855317300158?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889855317300158?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T18:25:40Z","timestamp":1535826340000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889855317300158"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":70,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["S0889855317300158"],"URL":"https:\/\/doi.org\/10.1016\/j.gtc.2017.01.004","relation":{},"ISSN":["0889-8553"],"issn-type":[{"value":"0889-8553","type":"print"}],"subject":[],"published":{"date-parts":[[2017,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Drug-induced Liver Injury","name":"articletitle","label":"Article Title"},{"value":"Gastroenterology Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gtc.2017.01.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}